NCT00604877

Brief Summary

This study examines the hypothesis that 6 months of treadmill aerobic exercise training improves fibrinolysis (clot defense mechanism) and vasomotor function in chronic hemiparetic (muscular weakness or partial paralysis restricted to one side of the body) stroke patients compared to a control intervention, and that these changes are associated with reduced plasma insulin levels and improved insulin sensitivity / glucose metabolism in this population.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
140

participants targeted

Target at P75+ for not_applicable stroke

Timeline
Completed

Started Aug 2003

Longer than P75 for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2003

Completed
4.5 years until next milestone

First Submitted

Initial submission to the registry

January 17, 2008

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 30, 2008

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2008

Completed
Last Updated

January 30, 2008

Status Verified

January 1, 2008

Enrollment Period

4.8 years

First QC Date

January 17, 2008

Last Update Submit

January 17, 2008

Conditions

Keywords

exerciseglucose metabolisminsulin sensitivityVascular Function

Outcome Measures

Primary Outcomes (4)

  • Resting and Post-Stressor Fibrinolysis

    Baseline and 6 months

  • Cerebral and lower extremity vasomotor reactivity

    Baseline and 6 months

  • Nitric oxide biomarkers

    Baseline and 6 months

  • Fasting insulin, HOMA-IR, post-load insulin response, glucose tolerance, insulin sensitivity, insulin signaling

    Baseline and 6 months

Secondary Outcomes (2)

  • Peak aerobic capacity

    Baseline and 6 months

  • Mobility Function (Timed walks etc..)

    Baseline and 6 months

Study Arms (2)

1

EXPERIMENTAL
Behavioral: Treadmill Exercise

2

ACTIVE COMPARATOR
Behavioral: Stretching/ROM

Interventions

3 times per week for 6 months, with target of 45 minutes at 60-70% heart rate range

1
Stretching/ROMBEHAVIORAL

3 times per week for 6 months, passive and active stretching and range of motion (ROM) exercises for the upper and lower extremities

2

Eligibility Criteria

Age40 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Ischemic Stroke greater than 6 months prior in men or women ages 40-85
  • Residual hemiparetic gait deficits
  • Already completed all conventional inpatient and outpatient physical therapy
  • Adequate language and neurocognitive function to participate in exercise testing and training

You may not qualify if:

  • Already performing greater than 20 minutes aerobic exercise 3 times per week
  • All insulin dependent diabetics; non-insulin dependent diabetics with fasting glucose greater than 180 mg/dl
  • Alcohol consumption greater than 2oz. liquor or equivalent per day
  • Cardiac history of: (a) unstable angina, (b) recent (less than 3 months) myocardial infarction, (c) symptomatic congestive heart failure, (d) hemodynamically significant valvular dysfunction
  • Medical History of: (a) recent (less than 3 months) hospitalization for severe medical disease, (b) PAOD (Peripheral Arterial Obstructive Disease) with claudication, (c) orthopedic or chronic pain condition restricting exercise, (d) pulmonary or renal failure, (e) active cancer, (f) poorly controlled hypertension (greater than 160/100) (g) Anemia defined by hematocrit less than 30
  • Neurological History of: (a) dementia with Mini-Mental Status Score less than 23 (less than 17 if education level at or below 8th grade), and diagnostic confirmation by neurologist or geropsychiatrist, (b) severe receptive or global aphasia which confounds testing and training, operationally defined as unable to follow 2 point commands, (c) hemiparetic gait from prior stroke preceding the index stroke defining eligibility, (d) non-stroke neurological disorder restricting exercise (e.g. Parkinson's Syndrome), (e) untreated major depression
  • Pregnancy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Baltimore VA Medical Center/ University of Maryland School of Medicine

Baltimore, Maryland, 21201, United States

Location

Related Publications (4)

  • Ivey FM, Ryan AS, Hafer-Macko CE, Goldberg AP, Macko RF. Treadmill aerobic training improves glucose tolerance and indices of insulin sensitivity in disabled stroke survivors: a preliminary report. Stroke. 2007 Oct;38(10):2752-8. doi: 10.1161/STROKEAHA.107.490391. Epub 2007 Aug 16.

    PMID: 17702957BACKGROUND
  • Ivey FM, Ryan AS, Hafer-Macko CE, Garrity BM, Sorkin JD, Goldberg AP, Macko RF. High prevalence of abnormal glucose metabolism and poor sensitivity of fasting plasma glucose in the chronic phase of stroke. Cerebrovasc Dis. 2006;22(5-6):368-71. doi: 10.1159/000094853. Epub 2006 Aug 3.

    PMID: 16888377BACKGROUND
  • Ivey FM, Macko RF, Ryan AS, Hafer-Macko CE. Cardiovascular health and fitness after stroke. Top Stroke Rehabil. 2005 Winter;12(1):1-16. doi: 10.1310/GEEU-YRUY-VJ72-LEAR.

    PMID: 15735997BACKGROUND
  • Ivey FM, Gardner AW, Dobrovolny CL, Macko RF. Unilateral impairment of leg blood flow in chronic stroke patients. Cerebrovasc Dis. 2004;18(4):283-9. doi: 10.1159/000080353. Epub 2004 Aug 24.

    PMID: 15331874BACKGROUND

MeSH Terms

Conditions

StrokeCerebrovascular DisordersMotor ActivityInsulin Resistance

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBehaviorHyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • Frederick M. Ivey, PhD

    University of Maryland, Baltimore

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
NIH

Study Record Dates

First Submitted

January 17, 2008

First Posted

January 30, 2008

Study Start

August 1, 2003

Primary Completion

May 1, 2008

Study Completion

May 1, 2008

Last Updated

January 30, 2008

Record last verified: 2008-01

Locations